Thomas Chalberg Biography

Co-founding and serving as CEO of Avalanche is Dr. Chalberg. By assembling the management team and scientific advisory board, as well as by managing commercial growth initiatives for in-licensing and research collaborations, he has advanced the firm. Dr. Chalberg worked in Genentech's ophthalmology division before joining Avalanche, where he helped create Lucentis, a cutting-edge treatment for age-related macular degeneration. His research on retinal illnesses and cutting-edge gene therapy techniques was conducted when he was a Stanford Howard Hughes Medical Institute Fellow. Dr. Chalberg graduated Phi Beta Kappa a magna cum laude from Harvard University, where he also earned an A.B. He received an MBA from the UC Berkeley Haas School of Business and a Ph.D. in genetics from the Stanford University School of Medicine. Tom is a member of Hope for Vision's Board of Visionary Scientists, a non-profit organization that funds vision research.

As a renowned expert and highly sought-after speaker, Thomas Chalberg's expertise is in high demand. To book Thomas Chalberg for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Thomas Chalberg's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Thomas Chalberg's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Thomas Chalberg for your next speaking engagement.